A Prognostic Model Based on NSUN3 Was Established to Evaluate the Prognosis and Response to Immunotherapy in Liver Hepatocellular Carcinoma

Figure 1

Analysis of NSUN3 expression and prognosis in LIHC and pathway enrichment analysis. (a) Expression level of NSUN3 in pan-cancer (TIMER database). (b) Differential expression of NSUN3 in LIHC and normal tissues. (c, d) Effects of NSUN3 expression level on overall survival (OS) and progression-free survival (PFS). (e) GO analysis based on NSUN3 expression level. (f) KEGG analysis based on NSUN3 expression level.

(a)

(b)

(c)

(d)

(e)

(f)